Trials / Completed
CompletedNCT01050127
A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The objectives of this study are to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of multiple doses of ABT-436 in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-436 | See Arm Description for details. |
| DRUG | Placebo | See Arm Description for details. |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-02-01
- First posted
- 2010-01-15
- Last updated
- 2010-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01050127. Inclusion in this directory is not an endorsement.